MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, TRVI has $179,606K in assets. $7,479K in debts. $19,412K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
2475.35%
Quick Ratio
2475.35%
Cash Ratio
272.83%
Debt to Asset Ratio
4.16%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Other non-current assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Total current liabilities
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
19,412 18,914 56,869 117,058
Marketable securities
152,371 169,346 138,058 86,827
Prepaid expenses
2,216 1,263 1,375 1,766
Other current assets
2,122 2,133 1,997 1,577
Total current assets
176,121 191,656 198,299 207,228
Operating lease right-of-use assets
610 677 741 804
Property, equipment and leasehold improvements
-537 --
Less accumulated depreciation and amortization
-359 --
Property, equipment and leasehold improvements, net
265 178 213 239
Other non-current assets
2,610 928 103 68
Finance lease right-of-use assets
-0 0 0
Total assets
179,606 193,439 199,356 208,339
Finance lease liabilities
-0 0 0
Accounts payable
2,215 3,911 2,709 2,974
Accrued expenses
4,582 5,531 6,036 5,981
Operating lease liabilities
318 307 296 286
Total current liabilities
7,115 9,749 9,041 9,241
Operating lease liabilities
364 446 527 605
Total liabilities
7,479 10,195 9,568 9,846
Common stock 0.001 par value 200,000,000 shares authorized at march 31, 2026 and december 31, 2025 and 128,411,048 and 128,306,056 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
128 128 128 122
Additional paid-in capital
515,185 512,772 511,118 508,033
Accumulated other comprehensive (loss) income
-190 148 30 24
Accumulated deficit
-342,996 -329,804 -321,488 -309,686
Total stockholders equity
172,127 183,244 189,788 198,493
Total liabilities and stockholders equity
179,606 193,439 199,356 208,339
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$152,371K Cash and cashequivalents$19,412K Prepaid expenses$2,216K Other current assets$2,122K Total current assets$176,121K Other non-currentassets$2,610K Operating leaseright-of-use assets$610K Property, equipment andleasehold improvements,...$265K Total assets$179,606K Total liabilities andstockholders equity$179,606K Total stockholdersequity$172,127K Total liabilities$7,479K Accumulated deficit-$342,996K Accumulated othercomprehensive (loss) income-$190K Additional paid-in capital$515,185K Total currentliabilities$7,115K Operating leaseliabilities$364K Common stock 0.001 parvalue 200,000,000...$128K Accrued expenses$4,582K Accounts payable$2,215K Operating leaseliabilities$318K

Trevi Therapeutics, Inc. (TRVI)

Trevi Therapeutics, Inc. (TRVI)